Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Roche identifies antagonists of Toll-like receptors

April 3, 2020

Butyrate affects regulatory B cells, rheumatoid arthritis

March 31, 2020

Roche synthesizes new TLR7/TLR8/TLR9 antagonists

March 30, 2020

Phase I data with inzomelid support progression to phase II

March 26, 2020

Aclaris initiates phase IIa study of ATI-450 with methotrexate for moderate to severe RA

March 16, 2020

Roche patents Toll-like receptor antagonists

March 13, 2020

Positive results presented from phase Ib portion of PREVAIL study of PRV-3279

March 13, 2020

New mouse model of Charcot arthropathy

March 13, 2020

Zhuhai United Laboratories patents new JAK1 and/or TYK2 inhibitors

March 10, 2020

BITRAP demonstrates promising efficacy in preclinical models of rheumatoid arthritis

March 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....